The Food and Drug Administration (FDA) last week approved Vraylar (cariprazine), a dopamine D2/D3 re...
In a paper published in the journal Translational Psychiatry, researchers from Johns Hopkins Univers...
The Food and Drug Administration approved the New Drug Application for Namzaric to treat moderate to...
The Food and Drug Administration (FDA) today issued a proposal designed to assist pharmaceutical com...
